Clinical Trials Logo
  1. Home
  2. Tourette's Disorder
  3. NCT00706589

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Tourette's Disorder Clinical Trial

Official title:
A Randomized, Double-blind, Dose-adjustment, Placebo-controlled Study to Evaluate the Efficacy and Safety of Aripiprazole in Children and Adolescents With Chronic Tic Disorders or Tourette's Disorder

Clinical Trial Summary

The purpose of this trial is to demonstrate the efficacy and safety of aripiprazole in children and adolescents aged 6~18 years with chronic tic disorders or Tourette's disorder

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00706589
Study type Interventional
Source Korea Otsuka Pharmaceutical Co.,Ltd.
Contact
Status Completed
Phase Phase 3
Start date October 2008
Completion date April 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT02316145 - Internet-based Coaching for Young Adults With Neuropsychiatric Disorders N/A
Completed NCT01416441 - Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Completed NCT01727700 - Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Recruiting NCT06408662 - Remote Delivery of a Mindfulness-based Intervention for Tics N/A
Completed NCT01315327 - Omega-3 Fatty Acids in Tourette's Disorder N/A
Completed NCT01795105 - ABF Tourette's Disorder Post Marketing Surveillance Study
Completed NCT01418339 - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Completed NCT01585207 - Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder Phase 1/Phase 2
Completed NCT01727713 - Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Completed NCT03042507 - Psychosocial Intervention for Young Children With Chronic Tics N/A
Completed NCT03508245 - Investigating Circadian Rhythms in Youth With Persistent Tic Disorders N/A
Completed NCT02864589 - Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder N/A
Completed NCT02413216 - TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT) N/A
Completed NCT01177774 - Assessment of Children With Tic Onset in the Past 6 Months
Completed NCT01418352 - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD) Phase 3
Recruiting NCT05499741 - Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder N/A
Completed NCT03916055 - Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder N/A